123 related articles for article (PubMed ID: 38241682)
1. Prognostic impact of the number and total tumor burden of secondary cerebral lesions in patients with resected brain metastases of non-small cell lung cancers.
Sauvageot S; Mollevi C; Thomas QD; Charissoux M; Darlix A; Rigau V; Bauchet L; Quantin X; Pujol JL; Roch B; Boetto J
J Neurosurg; 2024 Jan; ():1-11. PubMed ID: 38241682
[TBL] [Abstract][Full Text] [Related]
2. Resection of symptomatic non-small cell lung cancer brain metastasis in the setting of multiple brain metastases.
Jünger ST; Reinecke D; Meissner AK; Goldbrunner R; Grau S
J Neurosurg; 2022 Jun; 136(6):1576-1582. PubMed ID: 34715653
[TBL] [Abstract][Full Text] [Related]
3. Single brain metastases - prognostic factors and impact of residual tumor burden on overall survival.
Baumgart L; Anetsberger A; Aftahy AK; Wiestler B; Bernhardt D; Combs SE; Meyer HS; Schneider G; Meyer B; Gempt J
Front Oncol; 2024; 14():1330492. PubMed ID: 38559561
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Time Interval on Prognosis in Patients with Non-Small Cell Lung Cancer Brain Metastases After Metastases Surgery.
Yang Z; Chen H; Jin T; Sun L; Li L; Zhang S; Wu B; Jin K; Zou Y; Sun C; Xia L
World Neurosurg; 2023 Dec; 180():e171-e182. PubMed ID: 37704036
[TBL] [Abstract][Full Text] [Related]
5. Real-World Data on Prognostic Factors for Overall Survival in EGFR-Mutant Non-Small-Cell Lung Cancer Patients with Brain Metastases.
Yu X; Fan Y
J Cancer; 2019; 10(15):3486-3493. PubMed ID: 31293653
[No Abstract] [Full Text] [Related]
6. Survival analysis for lung adenosquamous carcinoma patients with brain metastasis.
Pan F; Cui S; Wang W; Gu A; Jiang L
J Cancer; 2018; 9(20):3707-3712. PubMed ID: 30405840
[No Abstract] [Full Text] [Related]
7. Brain metastases in the elderly - Impact of residual tumor volume on overall survival.
Baumgart L; Aftahy AK; Anetsberger A; Thunstedt D; Wiestler B; Bernhardt D; Combs SE; Meyer B; Meyer HS; Gempt J
Front Oncol; 2023; 13():1149628. PubMed ID: 37081991
[TBL] [Abstract][Full Text] [Related]
8. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
[TBL] [Abstract][Full Text] [Related]
9. Targeted Therapies and Utility of the Lung-molGPA in Non-Small-Cell Lung Cancer Patients with Brain Metastases.
Cacho-Díaz B; Cuapantécatl LD; Garcilazo-Reyes YJ; Cabrera-Miranda L; Hernandez-Martinez JM; Arrieta O
Oncology; 2022; 100(10):542-554. PubMed ID: 35988535
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors.
Hendriks LEL; Henon C; Auclin E; Mezquita L; Ferrara R; Audigier-Valette C; Mazieres J; Lefebvre C; Rabeau A; Le Moulec S; Cousin S; Duchemann B; le Pechoux C; Botticella A; Ammari S; Gazzah A; Caramella C; Adam J; Lechapt E; Planchard D; De Ruysscher D; Dingemans AM; Besse B
J Thorac Oncol; 2019 Jul; 14(7):1244-1254. PubMed ID: 30780002
[TBL] [Abstract][Full Text] [Related]
11. Anlotinib Combined with Cranial Radiotherapy for Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Retrospectively, Control Study.
He Z; Liu J; Ma Y; Jiang H; Cui Z; Wang G; Wu Y; Liu J; Cai X; Qian J; Huang J; Zhang H; Li H
Cancer Manag Res; 2021; 13():6101-6111. PubMed ID: 34377028
[TBL] [Abstract][Full Text] [Related]
12. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
13. Clinical determinants impacting overall survival of patients with operable brain metastases from non-small cell lung cancer.
Piffko A; Asey B; Dührsen L; Ristow I; Salamon J; Wikman H; Maire CL; Lamszus K; Westphal M; Sauvigny T; Mohme M
Front Oncol; 2022; 12():951805. PubMed ID: 36338751
[TBL] [Abstract][Full Text] [Related]
14. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
[TBL] [Abstract][Full Text] [Related]
15. Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma.
Du Y; Pahernik S; Hadaschik B; Teber D; Duensing S; Jäger D; Hohenfellner M; Grüllich C
J Neurooncol; 2016 Oct; 130(1):221-228. PubMed ID: 27538910
[TBL] [Abstract][Full Text] [Related]
16. Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs.
Gui Q; Liu J; Li D; Xu C
World J Surg Oncol; 2017 Oct; 15(1):184. PubMed ID: 29037198
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and outcome of surgically treated patients with brain metastases of non-small cell lung cancer.
She C; Wang R; Lu C; Sun Z; Li P; Yin Q; Liu Q; Wang P; Li W
Thorac Cancer; 2019 Feb; 10(2):137-142. PubMed ID: 30485664
[TBL] [Abstract][Full Text] [Related]
18. Survival and prognostic factors in patients undergoing the resection of solitary brain metastasis from non-small cell lung cancer: a retrospective cohort study.
Xu M; Song K; Zhou Z; Yu Z; Lv Y; Xu H
J Thorac Dis; 2022 Oct; 14(10):4113-4124. PubMed ID: 36389303
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria.
Roh YH; Park JE; Kang S; Yoon S; Kim SW; Kim HS
Cancer Imaging; 2023 Oct; 23(1):102. PubMed ID: 37875970
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and prognostic factors of brain metastases from colorectal cancer: a single center experience.
Gao Z; Jin X; Wu S
Int J Colorectal Dis; 2023 Jul; 38(1):198. PubMed ID: 37466736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
